Navigation Links
Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Date:8/19/2007

boration with Novartis Pharma AG

-- Continuing the development of oral heparin; discussions with the US

Food and Drug Administration (FDA) has established a pathway for

registration to proceed into complete Phase III for the use of oral

heparin in the prevention of deep-vein thrombosis following elective

total hip replacement. Emisphere is in current discussions with

potential partners to complete the development of oral heparin in a

collaborative arrangement.

-- Continuing clinical development of oral insulin; an insulin/glucose

clamp study with a new formulation is being planned over a three-month

period starting early in the first quarter, which will provide further

data and information on the dosage. Collaborative partnerships will

then be investigated

Emisphere has five products in Phase I:

-- An Investigational New Drug application (IND) was filed by Genta

Incorporated on gallium nitrate on July 31, 2007

-- A program continues on an improved oral formulation of the antiviral

compound acyclovir with a pharmaceutical company outside of the United

States

-- A food-intake study for both GLP-1 and PYY will be undertaken later

this year at University Hospital, Switzerland

-- Parathyroid hormone continues on a progressive clinical development

path in collaboration with Novaris Pharma AG

Emisphere has 11 products in preclinical development:

-- Six projects with partners in obesity, osteoporosis, infectious

disease, diabetes, and CNS

-- Five projects without established collaborations for the therapies of

CNS, erectile dysfunction, cardiovascular disease, inflammation and

pain, and fertility treatment

-- Following completion of these pre-clinical projects, decisions would

then be taken to possibly proceed into future collaborations
'/>"/>

SOURCE Emisphere Technologies, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 21, 2015 Research ... addition of the "Pharmaceutical Industry in China ... and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, ... to their offering. This report ... China but also home ...
(Date:7/28/2015)... 2015 P&S Market ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles ... Insulin Market Development and Demand Forecast to ... Explore more about Global Human Insulin ...
(Date:7/28/2015)... and LINCOLNSHIRE, Ill. , July 28, ... to leverage business acumen on par with their levels ... of Clinical Chemistry (AACC) Annual Meeting & Clinical Lab ... Better Box™ to deliver a comprehensive and intuitive ecosystem ... With advances in four key areas, Sysmex aims to ...
Breaking Medicine Technology:Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4
... Phase I Clinical Evaluation Anticoagulant Inhibits Clotting Factor IXa; ... Antidote Rapidly Reverses Anticoagulant Effect, ORLANDO, Fla., Nov. ... Ia and Phase Ib dose escalation,studies of the Company,s ... an aptamer-based anticoagulant, RB006,and its matched antidote, RB007, which ...
... population for company,s ... minimally invasive knee implant., MINNEAPOLIS, Nov. 6 ... announced today the,OrthoGlide Medial Knee Implant has been implanted in ... a minimally invasive device intended,to relieve pain caused by moderate ...
Cached Medicine Technology:Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions 2Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions 3The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement 2
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... By 2016, ... have the ability to engage with customers on a highly personal basis, increasing customer ... miss out on big growth opportunities or lose customers to more nimble competitors. , ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Edward Buckingham and ... Sudeep Roy in July 2016. Coming to Austin from Philadelphia, Dr. Roy will ... The twelve-month long training is facilitated annually by the American Academy of Facial Plastic ...
(Date:7/28/2015)... ... July 28, 2015 , ... Representatives with CareMed Urgent & ... support of National Immunization Awareness Month, which is the month of August. , ... illnesses like the flu, measles, and pneumonia, adults need to get their shots ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthline , a provider of intelligent ... (1) examining consumers’ perspectives on digital health . The survey, which was conducted ... innovations in digital health, level of trust in the security of digital health tools, ...
(Date:7/28/2015)... Jose, CA (PRWEB) , ... July 28, 2015 ... ... services, intelligent gateways, and embedded building blocks for edge devices that enable the ... equipped with 4th generation Intel® Core™ i7/i5 processor to provide exceptional computing power ...
Breaking Medicine News(10 mins):Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3
... Edward G.,Rendell today signed House Bill 1150 into ... for children and young,adults with Autism Spectrum Disorder., ... necessary treatments,for individuals with autism up to age ... services and treatments by building a stronger provider,network ...
... of Rochester Medical Center (URMC) will collaborate with the ... national repository of data that will aid academic and ... In addition to helping researchers understand many cardiac problems, ... to detect drugs that can have dangerous effects on ...
... CME company receives maximum term with commendation, ... notice from the Accreditation Council for Pharmacy Education,(ACPE) ... of continuing pharmacy,education for the maximum term with ... for Pharmacy Education as a,provider of continuing pharmacy ...
... This Summer and ... Throughout the Year, PINELLAS PARK, Fla., July ... and its effects on the skin, many,are not aware that the eyes ... Institute and Transitions Optical found that nearly 80,percent of consumers report knowing ...
... on legislation that would cut $358 million,from the ... 9 Seniors across Texas are,speaking out against ... being considered in the U.S. Senate. The legislation ... Advantage program in Texas,alone and severely cut back ...
... Warranted on Impact of Medicare Modernization Act,(MMA) to ... of,Longer Wait Times for Patients in Rural Locations, ... new study,released today in the July issue of ... patients experienced no major changes in their,access to ...
Cached Medicine News:Health News:Pennsylvania Governor Rendell Signs Bill Ensuring Continuity of Care for Children, Young Adults with Autism 2Health News:URMC, FDA to collaborate on national data repository for heart research 2Health News:URMC, FDA to collaborate on national data repository for heart research 3Health News:ArcMesa Educators Reaccredited as a Provider of Continuing Pharmacy Education 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 3Health News:Texas Seniors Speak Out Against Medicare Advantage Cuts 2Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: